Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-07 4:30 pm Sale | 13D | Akoya Biosciences, Inc. AKYA | Hudson Executive Capital LP | 1,892,204 4.99% | -555,354![]() (-22.69%) | View |
2022-12-02 4:15 pm Sale | 13D | Akoya Biosciences, Inc. AKYA | Hudson Executive Capital LP | 2,447,558 6.4% | -1,250,000![]() (-33.81%) | View |
2022-09-13 4:10 pm Purchase | 13D | Akoya Biosciences, Inc. AKYA | Hudson Executive Capital LP | 3,697,558 9.8% | 1,617,015![]() (+77.72%) | View |
2022-02-25 10:57 am Unchanged | 13G | Akoya Biosciences, Inc. AKYA | PSC Capital Partners LLC | 2,813,771 7.6% | 0 (Unchanged) | View |
2022-02-14 4:44 pm Unchanged | 13G | Akoya Biosciences, Inc. AKYA | Telegraph Hill Partners III, L.P. | 15,675,247 42.1% | 0 (Unchanged) | View |
2021-10-18 4:02 pm Purchase | 13D | Akoya Biosciences, Inc. AKYA | Hudson Executive Capital LP | 2,080,543 5.6% | 2,080,543![]() (New Position) | View |
2021-05-28 4:01 pm Purchase | 13G | Akoya Biosciences, Inc. AKYA | Telegraph Hill Partners III, L.P. | 15,675,247 42.7% | 15,675,247![]() (New Position) | View |